Genetics

Daniel A. Culver, DO
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Mary Jane Thomassen, PhD
Department of Pulmonary and Critical Care Medicine and the Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic

Mani S. Kavuru, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kavurum@ccf.org

Daniel A. Culver, DO
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Mary Jane Thomassen, PhD
Department of Pulmonary and Critical Care Medicine and the Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic

Mani S. Kavuru, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kavurum@ccf.org

Daniel A. Culver, DO
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Mary Jane Thomassen, PhD
Department of Pulmonary and Critical Care Medicine and the Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic

Mani S. Kavuru, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kavurum@ccf.org

John D. Clough, MD
Editor in Chief

John D. Clough, MD
Editor in Chief

John D. Clough, MD
Editor in Chief

Nancy L. Fisher, MD
Clinical Associate Professor, University of Washington; Member, Planning and Evaluation Committee for Ethical, Legal, and Social Implications, Human Genome Project

Nancy L. Fisher, MD
Clinical Associate Professor, University of Washington; Member, Planning and Evaluation Committee for Ethical, Legal, and Social Implications, Human Genome Project

Nancy L. Fisher, MD
Clinical Associate Professor, University of Washington; Member, Planning and Evaluation Committee for Ethical, Legal, and Social Implications, Human Genome Project

Maurie Markman, MD
Chairman, Department of Hematology/Medical Oncology and the Taussig Cancer Center, The Cleveland Clinic

Address: Maurie Markman, MD, Chairman, Taussig Cancer Center, Department of Hematology/Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail markmam@ccf.org

Maurie Markman, MD
Chairman, Department of Hematology/Medical Oncology and the Taussig Cancer Center, The Cleveland Clinic

Address: Maurie Markman, MD, Chairman, Taussig Cancer Center, Department of Hematology/Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail markmam@ccf.org

Maurie Markman, MD
Chairman, Department of Hematology/Medical Oncology and the Taussig Cancer Center, The Cleveland Clinic

Address: Maurie Markman, MD, Chairman, Taussig Cancer Center, Department of Hematology/Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail markmam@ccf.org

Carol A. Burke, MD
Department of Gastroenterology, The Cleveland Clinic

William M. Bauer, MD
Glen Falls Hospital, Glen Falls, New York

Bret Lashner, MD
Department of Gastroenterology, The Cleveland Clinic

Address: Carol A. Burke, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; email: burkec1@ccf.org

Dr. Burke has indicated that she has received grant or research support from Merck and Co.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Carol A. Burke, MD
Department of Gastroenterology, The Cleveland Clinic

William M. Bauer, MD
Glen Falls Hospital, Glen Falls, New York

Bret Lashner, MD
Department of Gastroenterology, The Cleveland Clinic

Address: Carol A. Burke, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; email: burkec1@ccf.org

Dr. Burke has indicated that she has received grant or research support from Merck and Co.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Carol A. Burke, MD
Department of Gastroenterology, The Cleveland Clinic

William M. Bauer, MD
Glen Falls Hospital, Glen Falls, New York

Bret Lashner, MD
Department of Gastroenterology, The Cleveland Clinic

Address: Carol A. Burke, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; email: burkec1@ccf.org

Dr. Burke has indicated that she has received grant or research support from Merck and Co.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Pyng Lee, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Thomas R. Gildea, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

James K. Stoller, MD, MS
Vice Chairman, Division of Medicine; Head, Section of Respiratory Therapy, Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic 

Address: James K. Stoller, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195

Dr. Stoller has indicated that he has received grant or research support from Alpha Therapeutics and that he is a consultant for Baxter Healthcare Corporation.

Geraldine M. McCarthy, MD
Department of Medicine, University College and Mater Misericordiae Hospital; and  Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin

Conor J. McCarthy, MD
Department of Medicine, University College and Mater Misericordiae Hospital, Dublin

Dermot Kenny, MD
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin

John Crowe, MD, PhD
Department of Medicine, University College and Mater Misericordiae Hospital, Dublin

Stephen Eustace, MB
Department of Radiology, University College and Mater Misericordiae Hospital, Dublin

Address: Geraldine M. McCarthy, MD, Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, 123, St. Stephen’s Green, Dublin 2, Ireland; e-mail: gmccarthy@rcsi.ie

Geraldine M. McCarthy, MD
Department of Medicine, University College and Mater Misericordiae Hospital; and  Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin

Conor J. McCarthy, MD
Department of Medicine, University College and Mater Misericordiae Hospital, Dublin

Dermot Kenny, MD
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin

John Crowe, MD, PhD
Department of Medicine, University College and Mater Misericordiae Hospital, Dublin

Stephen Eustace, MB
Department of Radiology, University College and Mater Misericordiae Hospital, Dublin

Address: Geraldine M. McCarthy, MD, Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, 123, St. Stephen’s Green, Dublin 2, Ireland; e-mail: gmccarthy@rcsi.ie

Geraldine M. McCarthy, MD
Department of Medicine, University College and Mater Misericordiae Hospital; and  Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin

Conor J. McCarthy, MD
Department of Medicine, University College and Mater Misericordiae Hospital, Dublin

Dermot Kenny, MD
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin

John Crowe, MD, PhD
Department of Medicine, University College and Mater Misericordiae Hospital, Dublin

Stephen Eustace, MB
Department of Radiology, University College and Mater Misericordiae Hospital, Dublin

Address: Geraldine M. McCarthy, MD, Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, 123, St. Stephen’s Green, Dublin 2, Ireland; e-mail: gmccarthy@rcsi.ie

Brian A. Clark, PhD, MD
Director, Medical Genetics, Taussig Cancer Center, Cleveland Clinic

Address: Brian A. Clark, PhD, MD, Taussig Cancer Center, T10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; email: clarkb@ccf.org

Brian A. Clark, PhD, MD
Director, Medical Genetics, Taussig Cancer Center, Cleveland Clinic

Address: Brian A. Clark, PhD, MD, Taussig Cancer Center, T10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; email: clarkb@ccf.org

Brian A. Clark, PhD, MD
Director, Medical Genetics, Taussig Cancer Center, Cleveland Clinic

Address: Brian A. Clark, PhD, MD, Taussig Cancer Center, T10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; email: clarkb@ccf.org